- Part 18: For the preceding part double click ID:nRSH4027Rq
state and federally operated health insurance exchanges. In general,
patients enrolled in the exchanges are subject to higher cost sharing
obligations and may not have as robust access to prescription drugs as
compared to patients enrolled in Medicare Part D or commercial plans.
Based, in part, on the impact of ACA to other healthcare sectors, there
is ongoing scrutiny of the US pharmaceutical industry that could result
in further government intervention and financial constraint. Many
stakeholders, including some in Congress and others in the broader
healthcare system, such as health plans, have dramatically increased
their criticism over the value of medicines in the US and have placed a
stronger emphasis on innovative therapies. Such criticism and focus on
the value of medicines has resulted in proposed policy and legislative
- More to follow, for following part double click ID:nRSH4027Rs